NO20002125L - FremgangsmÕter for fremstilling av 7- isoindolinkinolonkarboksylsyre-derivater og mellomprodukter for disse, salter av 7-isoindolinkinolonkarboksylsyrer, hydrater derav, og blanding inneholdende disse som aktiv bestandel - Google Patents

FremgangsmÕter for fremstilling av 7- isoindolinkinolonkarboksylsyre-derivater og mellomprodukter for disse, salter av 7-isoindolinkinolonkarboksylsyrer, hydrater derav, og blanding inneholdende disse som aktiv bestandel

Info

Publication number
NO20002125L
NO20002125L NO20002125A NO20002125A NO20002125L NO 20002125 L NO20002125 L NO 20002125L NO 20002125 A NO20002125 A NO 20002125A NO 20002125 A NO20002125 A NO 20002125A NO 20002125 L NO20002125 L NO 20002125L
Authority
NO
Norway
Prior art keywords
group
substituted
groups
isoindoline
protected
Prior art date
Application number
NO20002125A
Other languages
English (en)
Other versions
NO20002125D0 (no
NO318813B1 (no
Inventor
Minoru Yamada
Shoichi Hamamoto
Kazuya Hayashi
Kazuko Takaoka
Hiroko Matsukura
Minako Yotsuji
Kenji Yonezawa
Katsuji Ojima
Tamotsu Takamatsu
Kyoko Taya
Hirohiko Yamamoto
Taro Kiyoto
Hironori Kotsubo
Horohiko Yamamoto
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27525611&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20002125(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of NO20002125D0 publication Critical patent/NO20002125D0/no
Publication of NO20002125L publication Critical patent/NO20002125L/no
Publication of NO318813B1 publication Critical patent/NO318813B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20002125A 1997-10-27 2000-04-26 (R)-1-Cyklopropyl-8-difluormetoksy-7-(1-metyl-2,3-dihydro-1H-5-isoindolyl)-4-okso-1,4-dihydro-3-kinolinkarboksylsyremetansulfonat,(R)-1-Cyklopropyl-8-difluormetoksy-7-(1-metyl-2,3-dihydro-1H-5-isoindolyl)-4-okso-1,4-dihydro-3-kinolinkarboksylsyremetansulfonatmonohydrat og blandinger inneholdende disse NO318813B1 (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP31137697 1997-10-27
JP9280798 1998-03-20
JP14058698 1998-05-07
JP24482898 1998-08-31
JP25365698 1998-09-08
PCT/JP1998/004854 WO1999021849A1 (en) 1997-10-27 1998-10-27 Processes for producing 7-isoindolinequinolonecarboxylic derivatives and intermediates therefor, salts of 7-isoindolinequinolonecarboxylic acids, hydrates thereof, and composition containing the same as active ingredient

Publications (3)

Publication Number Publication Date
NO20002125D0 NO20002125D0 (no) 2000-04-26
NO20002125L true NO20002125L (no) 2000-06-07
NO318813B1 NO318813B1 (no) 2005-05-09

Family

ID=27525611

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20002125A NO318813B1 (no) 1997-10-27 2000-04-26 (R)-1-Cyklopropyl-8-difluormetoksy-7-(1-metyl-2,3-dihydro-1H-5-isoindolyl)-4-okso-1,4-dihydro-3-kinolinkarboksylsyremetansulfonat,(R)-1-Cyklopropyl-8-difluormetoksy-7-(1-metyl-2,3-dihydro-1H-5-isoindolyl)-4-okso-1,4-dihydro-3-kinolinkarboksylsyremetansulfonatmonohydrat og blandinger inneholdende disse
NO20042109A NO20042109L (no) 1997-10-27 2004-05-21 Fremgangsmate for fremstilling av 7-isoindolinkinolonkarboksylsyre-derivater og mellomprodukter for disse, salter av 7-isoindolinkinolonkarboksylsyrer, hydrater derav, og

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20042109A NO20042109L (no) 1997-10-27 2004-05-21 Fremgangsmate for fremstilling av 7-isoindolinkinolonkarboksylsyre-derivater og mellomprodukter for disse, salter av 7-isoindolinkinolonkarboksylsyrer, hydrater derav, og

Country Status (18)

Country Link
US (4) US6337399B1 (no)
EP (1) EP1031569B1 (no)
KR (2) KR100565362B1 (no)
CN (3) CN1296369C (no)
AT (1) ATE461186T1 (no)
AU (1) AU750760B2 (no)
CA (3) CA2593381C (no)
CY (1) CY1110242T1 (no)
DE (1) DE69841563D1 (no)
DK (1) DK1031569T3 (no)
ES (1) ES2341509T3 (no)
HU (1) HU229995B1 (no)
IL (2) IL135406A0 (no)
NO (2) NO318813B1 (no)
NZ (1) NZ504084A (no)
PT (1) PT1031569E (no)
TW (2) TWI242012B (no)
WO (1) WO1999021849A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1278717B1 (en) * 2000-03-07 2007-06-06 Ranbaxy Laboratories Limited One-pot synthesis of alkyl 3-cyclopropylamino-2- 2,4-dibromo-3-(difluoromethoxy)benzoyl|-2-propenoate as a useful intermediate for antibacterial quinolone medicaments
DE10111262A1 (de) * 2001-03-09 2002-09-12 Studiengesellschaft Kohle Mbh Verfahren zur Herstellung von Vinyl- Aryl- und Heteroarylessigsäuren und ihrer Devivate
US6777420B2 (en) 2001-06-15 2004-08-17 Microbiotix, Inc. Heterocyclic antibacterial compounds
JP2006151808A (ja) * 2002-12-24 2006-06-15 Dai Ichi Seiyaku Co Ltd 抗菌性水性製剤
US20090156577A1 (en) * 2004-09-09 2009-06-18 Benjamin Davis 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
RS55192B1 (sr) * 2005-11-24 2017-01-31 Dompé Farm S P A Derivati (r)-arilkilamina i farmaceutske kompozicije koje ih sadrže
US7902227B2 (en) * 2007-07-27 2011-03-08 Janssen Pharmaceutica Nv. C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents
CN101298418B (zh) * 2008-06-13 2010-12-15 江苏康鹏农化有限公司 3-氧代-3-(2,4-二卤代-3-二氟甲氧基苯基)丙酸乙酯的制备方法
JP5921826B2 (ja) * 2010-06-30 2016-05-24 富山化学工業株式会社 ５−ブロモ−２−（１−置換エチル）安息香酸エステルの新規製造法
MY165004A (en) 2011-08-31 2018-02-28 Otsuka Pharma Co Ltd Quinolone compound
WO2013121439A2 (en) * 2012-02-15 2013-08-22 Glenmark Generics Limited Process for garenoxacin mesylate
CN105837555B (zh) * 2016-03-31 2019-01-25 南京华威医药科技集团有限公司 加雷沙星及其中间体制备方法
CN105777631B (zh) * 2016-04-18 2018-06-29 浙江中欣氟材股份有限公司 一种1-环丙基-4-氧代-7-溴-8-二氟甲氧基-1,4-二氢喹啉-3-羧酸乙酯的合成方法
CN105801482B (zh) * 2016-04-18 2018-06-22 浙江中欣氟材股份有限公司 一种1-环丙基-4-氧代-7-溴-8-二氟甲氧基-1,4-二氢喹啉-3-羧酸乙酯的制备方法
CN106957255B (zh) * 2017-03-28 2018-01-09 上海馨远医药科技有限公司 一种(R)‑N‑Boc‑5‑溴‑1‑甲基异吲哚啉及其制备方法和应用
CN112028816B (zh) * 2020-09-11 2022-10-14 江阴迈康升华医药科技有限公司 一种取代异吲哚啉的合成方法
CN114105790A (zh) * 2021-12-14 2022-03-01 无锡捷化医药科技有限公司 一种3-氨基-4,5-二溴苯甲酸甲酯的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE245638T1 (de) * 1994-08-12 2003-08-15 Toyama Chemical Co Ltd Neue chinolon- oder naphthyridoncarbonsäurederivate oder deren salze
DE4431821A1 (de) * 1994-09-07 1996-03-14 Bayer Ag Verfahren zur Herstellung von N-Arylaminoacrylsäurederivaten und die Verwendung so hergestellter N-Arylaminoacrylsäurederivate zur Herstellung von 4-Chinolon-3-carbonsäurederivaten
WO1997029102A1 (en) * 1996-02-09 1997-08-14 Toyama Chemical Co., Ltd. Quinolonecarboxylic acid derivatives or salts thereof
JP4252282B2 (ja) * 2001-11-06 2009-04-08 富山化学工業株式会社 ２−［（１ｒ）−１−メチル−２−トリチル−２，３−ジヒドロ−１ｈ−５−イソインドリル］−１，３，６，２−ジオキサアザボロカンの非溶媒和物およびその製造法

Also Published As

Publication number Publication date
US20070225506A1 (en) 2007-09-27
CN1195752C (zh) 2005-04-06
HUP0101766A3 (en) 2002-10-28
ATE461186T1 (de) 2010-04-15
NO20042109L (no) 2000-06-07
CA2593381C (en) 2010-05-25
NO20002125D0 (no) 2000-04-26
CY1110242T1 (el) 2015-01-14
US6482835B2 (en) 2002-11-19
TW200420557A (en) 2004-10-16
US20050203301A1 (en) 2005-09-15
HU229995B1 (en) 2015-04-28
US6337399B1 (en) 2002-01-08
EP1031569B1 (en) 2010-03-17
AU9648698A (en) 1999-05-17
KR20010031474A (ko) 2001-04-16
US7371868B2 (en) 2008-05-13
CA2593381A1 (en) 1999-05-06
ES2341509T3 (es) 2010-06-21
CN1296369C (zh) 2007-01-24
TW593308B (en) 2004-06-21
NO318813B1 (no) 2005-05-09
AU750760B2 (en) 2002-07-25
KR20050055796A (ko) 2005-06-13
CA2307824C (en) 2008-02-19
CN1616455A (zh) 2005-05-18
PT1031569E (pt) 2010-05-10
NZ504084A (en) 2003-02-28
EP1031569A4 (en) 2003-04-23
IL135406A0 (en) 2001-05-20
CN1278257A (zh) 2000-12-27
IL135406A (en) 2006-10-05
HK1030779A1 (en) 2001-05-18
CA2307824A1 (en) 1999-05-06
KR100611869B1 (ko) 2006-08-11
EP1031569A1 (en) 2000-08-30
DK1031569T3 (da) 2010-05-10
TWI242012B (en) 2005-10-21
KR100565362B1 (ko) 2006-03-30
WO1999021849A1 (en) 1999-05-06
US20020049328A1 (en) 2002-04-25
CA2568251A1 (en) 1999-05-06
HUP0101766A2 (hu) 2001-12-28
CN1515555A (zh) 2004-07-28
DE69841563D1 (de) 2010-04-29

Similar Documents

Publication Publication Date Title
NO20002125D0 (no) FremgangsmÕter for fremstilling av 7- isoindolinkinolonkarboksylsyre-derivater og mellomprodukter for disse, salter av 7-isoindolinkinolonkarboksylsyrer, hydrater derav, og blanding inneholdende disse som aktiv bestandel
FI970578A0 (fi) Uusia kinoloni- tai naftyridonikarboksyylihappojohdannaisia tai niiden suola
PT976748E (pt) Derivados de pirrolidina com actividade inibidora de fosfolipase a2
DE69824450D1 (de) Biphenylamidin-derivate
DE69931051D1 (de) Neue vinylbenzolderivate
DE60016384D1 (de) Chondrogonese promotoren und indolin-2-on derivate
DK0806413T3 (da) 2-substituerede viatmin D3-derivater
EP1034783A4 (en) AMIDE DERIVATIVES
ATE349462T1 (de) Thiazolidin-derivate
DE69231244D1 (de) Pyrazolothiazolopyrimidin-derivate
AU1735397A (en) Pyridonecarboxylic acid derivatives and intermediates for the synthesis thereo
BR9605109A (pt) Derivados de ésteres de ácidos carboxílicos processo de fabricação dos mesmos inseticidas e agentes de proteção contra insetos

Legal Events

Date Code Title Description
MK1K Patent expired